Objective: To determine the efficacy and tolerability of low-dose tamsulosin 0.2 mg/day in Chinese ... (I-PSS), quality-of-life (QOL) index and maximum urinary flow rate (Q max) ...

Patients received tamsulosin daily for a median period of 10 months, with median follow-up of 25 months. Treatment was associated with an 86% improvement in weekly incontinence episodes and a 40% ...

tamsulosin monotherapy, economic analyses have been conducted in the UK, [10] Canada, [11] Spain, [12] and Scandinavia, [13] where the fixed-dose combination therapy was shown to be cost-effective ...